NO20090322L - 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor - Google Patents
6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitorInfo
- Publication number
- NO20090322L NO20090322L NO20090322A NO20090322A NO20090322L NO 20090322 L NO20090322 L NO 20090322L NO 20090322 A NO20090322 A NO 20090322A NO 20090322 A NO20090322 A NO 20090322A NO 20090322 L NO20090322 L NO 20090322L
- Authority
- NO
- Norway
- Prior art keywords
- hiv
- inhibitor
- agent
- compound
- integrave
- Prior art date
Links
- 125000001797 benzyl group Chemical class [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000002259 anti human immunodeficiency virus agent Substances 0.000 abstract 4
- 229940124411 anti-hiv antiviral agent Drugs 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 108010002459 HIV Integrase Proteins 0.000 abstract 1
- 229940099797 HIV integrase inhibitor Drugs 0.000 abstract 1
- 102100034343 Integrase Human genes 0.000 abstract 1
- 108010061833 Integrases Proteins 0.000 abstract 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003084 hiv integrase inhibitor Substances 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006174331 | 2006-06-23 | ||
| JP2006220082 | 2006-08-11 | ||
| JP2006274143 | 2006-10-05 | ||
| PCT/JP2007/062579 WO2007148780A1 (fr) | 2006-06-23 | 2007-06-22 | Composé 6-(benzyle substituté par hétérocycle)-4-oxoquinoline et utilisation de celui-ci comme inhibiteur de l'intégrase du vih |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090322L true NO20090322L (no) | 2009-03-20 |
Family
ID=38833517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090322A NO20090322L (no) | 2006-06-23 | 2009-01-21 | 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7872004B2 (fr) |
| EP (2) | EP2033954A4 (fr) |
| JP (1) | JP4038231B1 (fr) |
| KR (1) | KR101053811B1 (fr) |
| AR (1) | AR061583A1 (fr) |
| AU (1) | AU2007262010B2 (fr) |
| BR (1) | BRPI0713336A2 (fr) |
| CA (1) | CA2653830C (fr) |
| CL (1) | CL2007001838A1 (fr) |
| CO (1) | CO6150181A2 (fr) |
| IL (1) | IL195862A0 (fr) |
| MX (1) | MX2009000159A (fr) |
| MY (1) | MY144773A (fr) |
| NO (1) | NO20090322L (fr) |
| NZ (1) | NZ573709A (fr) |
| PE (1) | PE20080211A1 (fr) |
| SA (1) | SA07280343B1 (fr) |
| TW (1) | TW200811153A (fr) |
| WO (1) | WO2007148780A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK2662004A3 (sk) * | 2002-11-20 | 2005-06-02 | Japan Tobacco, Inc. | Zlúčenina s obsahom 4-oxochinolínu a jej použitie ako inhibítora integráz |
| WO2008033836A2 (fr) * | 2006-09-12 | 2008-03-20 | Gilead Sciences, Inc. | Processus et intermédiaires destinés à préparer des inhibiteurs d'intégrase |
| AR068403A1 (es) * | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
| ES2446720T3 (es) | 2009-10-13 | 2014-03-10 | Elanco Animal Health Ireland Limited | Inhibidores de la integrasa macrocíclica |
| WO2011121105A1 (fr) | 2010-04-02 | 2011-10-06 | Tibotec Pharmaceuticals | Inhibiteurs de l'intégrase macrocyclique |
| ES3018133T3 (en) | 2011-11-30 | 2025-05-14 | Univ Emory | Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae |
| AU2013296289B2 (en) | 2012-08-03 | 2017-10-05 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
| MY201239A (en) | 2019-03-22 | 2024-02-13 | Gilead Sciences Inc | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
| PE20221569A1 (es) | 2020-02-24 | 2022-10-06 | Gilead Sciences Inc | Compuestos tetraciclicos para el tratamiento de infecciones por vih |
| ES3064867T3 (en) | 2020-09-30 | 2026-04-29 | Gilead Sciences Inc | Bridged tricyclic carbamoylpyridone compounds for a use in the treatment of hiv |
| US11613546B2 (en) | 2021-01-19 | 2023-03-28 | Gilead Sciences, Inc. | Substituted pyridotriazine compounds and uses thereof |
| TW202446773A (zh) | 2022-04-06 | 2024-12-01 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
| CN115448866B (zh) * | 2022-10-13 | 2023-11-21 | 中北大学 | 一种1-甲基-2,3,4,5-四硝基吡咯的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK286420B6 (sk) | 1997-09-15 | 2008-09-05 | The Procter & Gamble Company | Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie |
| WO2004004611A1 (fr) | 2002-07-08 | 2004-01-15 | Coloplast A/S | Tube |
| SK2662004A3 (sk) | 2002-11-20 | 2005-06-02 | Japan Tobacco, Inc. | Zlúčenina s obsahom 4-oxochinolínu a jej použitie ako inhibítora integráz |
| EP1730135B1 (fr) | 2004-03-10 | 2010-09-22 | The United States of America, represented by the Secretary, Department of Health and Human Services | Quinolin-4-ones utilises comme inhibiteurs de l'integrase retrovirale pour le traitement du vih, du sida et du syndrome apparente au sida (arc) |
| US7531554B2 (en) | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
| WO2006033422A1 (fr) | 2004-09-21 | 2006-03-30 | Japan Tobacco Inc. | Compose de quinolizinone et utilisation de celui-ci en tant qu'inhibiteur de l'integrase du vih |
| US7745459B2 (en) | 2004-09-21 | 2010-06-29 | Japan Tobacco Inc. | Quinolizinone compound and use thereof as HIV integrase inhibitor |
| JP2006174331A (ja) | 2004-12-20 | 2006-06-29 | Fuji Xerox Co Ltd | 画像圧縮装置、画像圧縮方法及びそのプログラム |
| JP2006220082A (ja) | 2005-02-10 | 2006-08-24 | Denso Corp | 燃料噴射装置 |
| JP4572720B2 (ja) | 2005-03-30 | 2010-11-04 | Ｄｉｃ株式会社 | 水分散型アクリル系樹脂の製造方法、並びにそれにより製造される水分散型アクリル粘着剤組成物及び粘着シート |
| DE102006005861A1 (de) | 2006-02-09 | 2007-08-23 | Aicuris Gmbh & Co. Kg | Substituierte Chinolone III |
-
2007
- 2007-06-21 TW TW096122234A patent/TW200811153A/zh unknown
- 2007-06-22 AR ARP070102755A patent/AR061583A1/es not_active Application Discontinuation
- 2007-06-22 EP EP07845259A patent/EP2033954A4/fr not_active Withdrawn
- 2007-06-22 EP EP11168760A patent/EP2368880A1/fr not_active Withdrawn
- 2007-06-22 AU AU2007262010A patent/AU2007262010B2/en not_active Ceased
- 2007-06-22 US US11/767,021 patent/US7872004B2/en not_active Expired - Fee Related
- 2007-06-22 WO PCT/JP2007/062579 patent/WO2007148780A1/fr not_active Ceased
- 2007-06-22 NZ NZ573709A patent/NZ573709A/en not_active IP Right Cessation
- 2007-06-22 KR KR1020097001497A patent/KR101053811B1/ko not_active Expired - Fee Related
- 2007-06-22 MX MX2009000159A patent/MX2009000159A/es active IP Right Grant
- 2007-06-22 JP JP2007164676A patent/JP4038231B1/ja not_active Expired - Fee Related
- 2007-06-22 BR BRPI0713336-7A patent/BRPI0713336A2/pt not_active IP Right Cessation
- 2007-06-22 CL CL200701838A patent/CL2007001838A1/es unknown
- 2007-06-22 PE PE2007000805A patent/PE20080211A1/es not_active Application Discontinuation
- 2007-06-22 CA CA2653830A patent/CA2653830C/fr not_active Expired - Fee Related
- 2007-06-23 SA SA7280343A patent/SA07280343B1/ar unknown
-
2008
- 2008-12-10 MY MYPI20085006A patent/MY144773A/en unknown
- 2008-12-11 IL IL195862A patent/IL195862A0/en unknown
-
2009
- 2009-01-16 CO CO09003378A patent/CO6150181A2/es unknown
- 2009-01-21 NO NO20090322A patent/NO20090322L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY144773A (en) | 2011-10-31 |
| BRPI0713336A2 (pt) | 2012-11-06 |
| CL2007001838A1 (es) | 2008-02-08 |
| TW200811153A (en) | 2008-03-01 |
| JP2008110960A (ja) | 2008-05-15 |
| CA2653830C (fr) | 2011-11-22 |
| KR101053811B1 (ko) | 2011-08-03 |
| IL195862A0 (en) | 2009-09-01 |
| JP4038231B1 (ja) | 2008-01-23 |
| EP2033954A1 (fr) | 2009-03-11 |
| PE20080211A1 (es) | 2008-04-23 |
| AU2007262010A1 (en) | 2007-12-27 |
| EP2368880A1 (fr) | 2011-09-28 |
| AR061583A1 (es) | 2008-09-03 |
| CO6150181A2 (es) | 2010-04-20 |
| CA2653830A1 (fr) | 2007-12-27 |
| SA07280343B1 (ar) | 2011-01-15 |
| NZ573709A (en) | 2011-04-29 |
| KR20090023731A (ko) | 2009-03-05 |
| MX2009000159A (es) | 2009-01-23 |
| AU2007262010B2 (en) | 2011-05-12 |
| WO2007148780A1 (fr) | 2007-12-27 |
| EP2033954A4 (fr) | 2009-08-12 |
| US20080207618A1 (en) | 2008-08-28 |
| US7872004B2 (en) | 2011-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090322L (no) | 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor | |
| TW200510425A (en) | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor | |
| MY136173A (en) | 4-oxoquinoline compound and use thereof as hiv integrase inhibitor | |
| NO20045152L (no) | Ikke-nukleosid-reverstranskriptaseinhibitorer | |
| NO20080913L (no) | HIV-revers-transriptaseinhibitorer | |
| EA200970572A1 (ru) | Ненуклеозидные ингибиторы обратной транскриптазы | |
| NO20063958L (no) | HIV integrase inhibitorer | |
| MX2019007262A (es) | Compuestos antivirales de bencilamina fosfodiamida. | |
| MA34002B1 (fr) | Thérapie antivirale | |
| CA2998646C (fr) | Inhibiteurs nucleosidiques de la transcriptase inverse substitues en position 4' et preparations associees | |
| UA114006C2 (xx) | Похідні 5-фенокси-3h-піримідин-4-ону і їхнє застосування як інгібіторів зворотної транскриптази віл | |
| GEP20156368B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| CL2008003786A1 (es) | Compuestos derivados de 1h-pirazolo[3,4-c]piridazinilo, 1h pirazolo[3,4-b]piridinilo, ah-pirazolo[3,4-c]piridinilo e indazolilo, inhibidores no nucleosidicos de la transcriptasa reversa del vih-1(nnrti); composicion fa<rma<ceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por viv, sida o arc. | |
| EA200601654A1 (ru) | Ингибиторы интегразы вич | |
| MX2021007069A (es) | 3,3-difluoroalilaminas o sales de las mismas y composiciones farmaceuticas que comprenden las mismas. | |
| GEAP202014873A (en) | Methods for treatment and prophylaxis of hiv and aids | |
| CO6531485A2 (es) | Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa | |
| EA201170537A1 (ru) | Ингибиторы вич-интегразы | |
| EA202191711A1 (ru) | Производные пиримидона в качестве селективных цитотоксических агентов против вич-инфицированных клеток | |
| WO2016086153A3 (fr) | Utilisation de dérivés de tétrahydroindazolylbenzamide et tétrahydroindolylbenzamide pour le traitement du virus de l'immunodéficience humaine (vih) et du syndrome d'immunodéficience acquise (sida) | |
| TW200738700A (en) | HIV integrase inhibitors | |
| SG155939A1 (en) | Phosphoindoles as hiv inhibitors | |
| WO2006083553A3 (fr) | Acides diceto a squelettes nucleobase: inhibiteurs de replication anti-vih cible au niveau de l'integrase du vih | |
| MX2022011138A (es) | Efecto contra coronavirus y aplicacion de inhibidor de fosfatidilinositol 4-cinasa. | |
| GEAP202415952A (en) | Pyrimidine-based bicycles as antiviral agents for the treatment and prevention of hiv infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |